FORT LAUDERDALE, Fla., Sept. 28, 2005 (PRIMEZONE) -- Linkwell Corporation (OTCBB:LWLL), a leading manufacturer and distributor of healthcare disinfectant products in China announced that it received clearance from the Ministry of Health Care of China to sell a revised version of the widely used 84' disinfectant throughout mainland China.
Generic 84' disinfectant is a chlorine-based disinfectant that is used extensively in China since it was first introduced in 1984. The new and improved version of this disinfectant will be marketed under the name Likang 84'. Likang 84' has a significantly longer shelf life than its predecessor from three months to two years. Management believes the extended shelf life will give their brand a competitive advantage at retail in this estimated $100 million USD market in China.
As a result of an extensive R&D process, the new Likang 84' has a shelf life of over 2 years. Previous versions of the generic 84' disinfectant had a shelf life of only three months. Likang 84 disinfectant is the first of the 84' disinfectant with an extended shelf life approved by Ministry of Health Care of China. In addition, Likang's new 84' disinfectant substantially reduces irritation and corrosion that other 84' disinfectants may cause.
"We are very excited with the economic potential of the new and improved Likang 84'," said CEO Xuelian Bian. "With the recent public epidemics of SARS and bird flu virus, there is clearly a need for improved disinfectant products, and we believe we have the best product and most competitive pricing in the Chinese market. We plan to aggressively market this new product through major supermarket chains in China. A small percentage of market penetration can generate millions for Linkwell. We believe this new product will be one of our major revenues and earnings generators for years to come," Bian added.
About Linkwell Corporation
Linkwell Corporation ("Linkwell") is doing business in disinfectant industry in China through its subsidiary in China. Linkwell owns 90% of Shanghai Likang Disinfectant Company, Limited ("Likang"). Likang, a leading manufacturer and distributor of healthcare disinfectant products in China, was founded in 1988. Likang is involved in the research and development, production, marketing, sale, and distribution of disinfectant health care products. Likang's products are utilized by the hospital and medical industry in China. Likang has developed a line of disinfectant product offerings. With the research and development, unique technology and the competitive advantages of numerous professional staff rooms of the Second Military Medical University, Likang has developed and manufactured a series of products in the field of skin mucous disinfection, hand disinfection, surrounding articles disinfection, medical instruments disinfection and air disinfection. For more info about the Company, please visit http://www.linkwell.us
Safe Harbor Statement
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets.